Profound Medical Corp. (NASDAQ: PROF) reported Q1 EPS of $0.32, $0.69 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.86 million versus the consensus estimate of $2.12 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.